Navigation Links
Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
Date:10/30/2008

RICHMOND, Va., Oct. 30 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today reported results for the third quarter and nine-months ended September 30, 2008.

Recent Company Highlights

-- Follow-on Biologics Program

-- Received approval from the United Kingdom's Medicines and

Healthcare products Regulatory Agency to initiate a Phase I clinical

study for the Company's second follow-on biologic

("FOB") product candidate, INS-20. Insmed's INS-20

is a pegylated recombinant form of human G-CSF, and an FOB of the

FDA-approved product Neulasta(R), which had U.S. sales of

approximately $2.4 billion in 2007.

-- IPLEX(TM)

-- Received $3.0 million in cost recovery revenue in the third quarter

related to the expanded access program ("EAP") for

IPLEX(TM). The EAP in Italy to treat patients with Amyotrophic

Lateral Sclerosis ("ALS"), also known as Lou Gehrig's

Disease, currently includes 23 physicians and over 100 subjects have

enrolled;

-- Announced the presentation of clinical study results with Premacure

demonstrating IPLEX(TM) increased serum IGF-I levels into the normal

range in significantly premature infants. Premacure is developing

IPLEX(TM) as a potential treatment for Retinopathy of Prematurity

("ROP") via a Material Transfer Agreement with Insmed.

Based in part on the results of this study, Premacure intends to

initiate a phase II multicenter trial in the ROP indication during

the fourth quarter.

"We continue to execute on our business plan and efficiently advance each of our key clinical programs," said Dr. Geoffrey Allan, President and CEO of Insmed. "Our second FOB ca
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
2. Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule
3. Insmed to Seek Shareholder Approval for Reverse Split
4. Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
5. Insmed to Present at Biosimilars 2008 Conference
6. Insmed to Present at BioPharm Asia 2008 Conference
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. Insmed CEO to Present at Drug Discovery & Development Conference
9. Insmed to Host Second Quarter 2008 Conference Call
10. Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor
11. Insmed Retains RBC Capital Markets as Strategic Financial Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... to biotechnology firms has revealed early bottlenecks on ... the researchers suggest that better communication of basic ... to faster commercialization down the road. , Biopharmaceutical ... university laboratories and licensed to biotechnology firms. Bottlenecks ... a high failure rate. But a new study ...
(Date:8/20/2014)... Aug. 20, 2014  Decision Resources Group finds that the vascular ... Russia , India and ... 2013, roughly equal to the size of the United ... market will experience much faster growth as a result of strong ... Other key findings from Decision Resources Group,s coverage of the ...
(Date:8/20/2014)... in your ear could improve the health of your ... University of Leeds used a standard TENS machine like ... pulses to the tragus, the small raised flap at ... the ear canal. , The stimulation changed the influence ... the nervous signals that can drive failing hearts too ...
(Date:8/19/2014)... DUBLIN , Aug. 19, 2014 Research and ... Culture Supplies - Global Strategic Business Report" report to their ... Cell and Tissue Culture Supplies in US$ Thousands by the following ... separate comprehensive analytics for the US, Canada , ... Asia-Pacific , and Latin America . ...
Breaking Biology Technology:Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3'Tickling' your ear could be good for your heart 2Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2
... - For Effective ... EMBASE(R), Elsevier,s biomedical and pharmaceutical ... with QUOSA(TM) to enable,mutual customers to download and manage ... established EMBASE.com channel in QUOSA Information,Manager. , ...
... WAYNE, Pa., Nov. 28 Encorium Group, Inc.,(Nasdaq: ... organization,(CRO) conducting studies in over 30 countries for many ... that on November,21, 2008, it received a letter from ... 10-Q for the quarterly period ended September 30, 2008 ...
... SAN DIMAS, Calif., Nov. 28 Why Humans ... Bill Sardi, co-founder and formulator of Longevinex(R) (long-jev-in-ex), a nutriceutical product ... To view the Multimedia News Release, go to: , ... The film presents the " overmineralization " theory of aging ...
Cached Biology Technology:Elsevier's EMBASE.com Partners With QUOSA 2Elsevier's EMBASE.com Partners With QUOSA 3Elsevier's EMBASE.com Partners With QUOSA 4Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing 2Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing 3Video: 8-Minute Film Documentary Explores Why Humans Age 2
(Date:8/20/2014)... Health has awarded the Oklahoma Medical Research Foundation a ... anthrax and the bacteria,s effects on humans. , ... his colleagues have studied the human immune response to ... Human Immunology. The original funding came soon after anthrax-laced ... of the terrorist attacks of Sept. 11, 2001. ...
(Date:8/20/2014)... the past few years, Virginia Tech,s Wu Feng has ... grant from the "Computing in the Cloud" program, and ... $6 million award from the Air Force on "big ... NSF and the National Institutes of Health on "big ... together the "parallel computing" aspects from each grant, he ...
(Date:8/20/2014)... Carolina State University researchers have developed methods for electronically ... the electrical signals moths use to control those muscles. ... remotely-controlled moths, or "biobots," for use in emergency response. ... whether we can control the movement of moths for ... says Dr. Alper Bozkurt, an assistant professor of electrical ...
Breaking Biology News(10 mins):$14.5 million grant awarded to continue anthrax studies 2The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4Research paves way for development of cyborg moth 'biobots' 2
... EAST LANSING, Mich. -- Time marches on, ... of wildlife habitat now can monitor changes over ... and projecting future changes are essential for sustainable ... wildlife habitat," said Jianguo "Jack" Liu, Rachel Carson ...
... in The FASEB Journal ( http://www.faseb.org ) suggests that pregnant ... babies who are likely to become junk food junkies themselves. ... the high fat and high sugar diet leads to changes ... only does this offer insight into the ever-increasing rate of ...
... 23, 2011 -- Structural studies of some of ... way for new generations of biologically inspired solar ... St. Louis and the Department of Energy,s Oak ... analyze the structure of chlorosomes in green photosynthetic ...
Cached Biology News:'Junk food' moms have 'junk food' babies 2Neutron analysis yields insight into bacteria for solar energy 2
Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
Anti Human S14G-Humanin Polyclonal Antibody...
... familiar interface for data capture, recording, ... transition from paper to this powerful ... contains an integrated LIMS, notary service, ... These functions allow LABTrack to achieve ...
High voltage electrophoresis power supply...
Biology Products: